Literature DB >> 6423232

Serum vitamin D metabolites in younger and elderly postmenopausal women.

C Christiansen, P Rødbro.   

Abstract

Previous investigations have suggested that a lower-than-normal serum 1,25(OH)2D is found in elderly women with postmenopausal osteoporosis. We examined the fundamental aspects of this theory by investigating serum vitamin D metabolites in four representative samples of Caucasian women. These included 44 early postmenopausal women divided into two subgroups: fast bone losers, that is, bone loss greater than 3%/year (n = 20), and "physiological" bone loss (n = 24); and 28 70-year-old women divided into two subgroups: with and without osteoporotic fractures. Serum 1,25(OH)2D concentrations were virtually the same in all groups thus contradicting the previous reports of low 1,25(OH)2D in elderly women. Furthermore, mean 25OHD and 24,25(OH)2D did not differ between the groups. We conclude that 1,25(OH)2D is unlikely to be significant in the development or treatment of a majority of women with postmenopausal osteoporosis.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6423232     DOI: 10.1007/bf02405289

Source DB:  PubMed          Journal:  Calcif Tissue Int        ISSN: 0171-967X            Impact factor:   4.333


  27 in total

1.  Intestinal calcium absorption and serum vitamin D metabolites in normal subjects and osteoporotic patients: effect of age and dietary calcium.

Authors:  J C Gallagher; B L Riggs; J Eisman; A Hamstra; S B Arnaud; H F DeLuca
Journal:  J Clin Invest       Date:  1979-09       Impact factor: 14.808

2.  Seasonal variation of histological osteomalacia in femoral-neck fractures.

Authors:  J E Aaron; J C Gallagher; B E Nordin
Journal:  Lancet       Date:  1974-07-13       Impact factor: 79.321

3.  A possible direct effect of 24,25-dihydroxycholecalciferol on the parathyroid gland in patients with chronic renal failure.

Authors:  C Christiansen; P Rødbro; J Naestoft; M S Christensen
Journal:  Clin Endocrinol (Oxf)       Date:  1981-09       Impact factor: 3.478

4.  The relation of total body potassium to height, weight, and age in normal adults.

Authors:  K Boddy; P C King; R Hume; E Weyers
Journal:  J Clin Pathol       Date:  1972-06       Impact factor: 3.411

Review 5.  Recent advances in our understanding of the vitamin D endocrine system.

Authors:  H F De Luca
Journal:  J Lab Clin Med       Date:  1976-01

6.  Treatment of post menopausal osteoporosis. A controlled therapeutic trial comparing oestrogen/gestagen, 1,25-dihydroxy-vitamin D3 and calcium.

Authors:  G F Jensen; C Christiansen; I Transbøl
Journal:  Clin Endocrinol (Oxf)       Date:  1982-05       Impact factor: 3.478

7.  1,25-Dihydroxyvitamin D3: short- and long-term effects on bone and calcium metabolism in patients with postmenopausal osteoporosis.

Authors:  J C Gallagher; C M Jerpbak; W S Jee; K A Johnson; H F DeLuca; B L Riggs
Journal:  Proc Natl Acad Sci U S A       Date:  1982-05       Impact factor: 11.205

8.  Prevention of early postmenopausal bone loss: controlled 2-year study in 315 normal females.

Authors:  C Christiansen; M S Christensen; P McNair; C Hagen; K E Stocklund; I Transbøl
Journal:  Eur J Clin Invest       Date:  1980-08       Impact factor: 4.686

9.  Long-term reproducibility of bone mineral content measurements.

Authors:  C Christiansen; P Rödbro
Journal:  Scand J Clin Lab Invest       Date:  1977-06       Impact factor: 1.713

10.  Bone mineral content before and after intestinal bypass operation in obese patients.

Authors:  H Rickers; I Balslev; H Foltved; P Rødbro
Journal:  Acta Med Scand       Date:  1981
View more
  8 in total

1.  The role of serum concentrations of sex steroids and bone turnover in the development and occurrence of postmenopausal osteoporosis.

Authors:  B J Riis; P Rødbro; C Christiansen
Journal:  Calcif Tissue Int       Date:  1986-06       Impact factor: 4.333

Review 2.  Risk factors for osteoporosis and associated fractures.

Authors:  J L Kelsey
Journal:  Public Health Rep       Date:  1989 Sep-Oct       Impact factor: 2.792

3.  Serum concentration of vitamin D metabolites in rheumatoid arthritis.

Authors:  O S Als; B Riis; C Christiansen
Journal:  Clin Rheumatol       Date:  1987-06       Impact factor: 2.980

4.  Parathyroid hormone, 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D concentration in elderly patients.

Authors:  P Oster; T Müller; H Schmidt-Gayk; G Schlierf
Journal:  Klin Wochenschr       Date:  1990-04-17

Review 5.  Osteoporosis, calcium and physical activity.

Authors:  A D Martin; C S Houston
Journal:  CMAJ       Date:  1987-03-15       Impact factor: 8.262

6.  Comparison of vitamin D metabolism in early healthy and late osteoporotic postmenopausal women.

Authors:  D Hartwell; B J Riis; C Christiansen
Journal:  Calcif Tissue Int       Date:  1990-12       Impact factor: 4.333

7.  Decrease in bone level of 1,25-dihydroxyvitamin D in women over 45 years old.

Authors:  P Sagiv; C Lidor; T Hallel; S Edelstein
Journal:  Calcif Tissue Int       Date:  1992-07       Impact factor: 4.333

Review 8.  Calcitriol. A review of its use in the treatment of postmenopausal osteoporosis and its potential in corticosteroid-induced osteoporosis.

Authors:  K L Dechant; K L Goa
Journal:  Drugs Aging       Date:  1994-10       Impact factor: 3.923

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.